Headache 2002-Jun
Hemicrania continua responds to cyclooxygenase-2 inhibitors.
Články môžu prekladať iba registrovaní používatelia
Prihlásiť Registrácia
Odkaz sa uloží do schránky
Kľúčové slová
Abstrakt
BACKGROUND
Hemicrania continua is a primary headache disorder defined by its absolute responsiveness to indomethacin. We report the treatment response to two cyclooxygenase-2 inhibitors, celecoxib and rofecoxib, in a series of patients with hemicrania continua.
METHODS
Fourteen patients were treated, 9 with rofecoxib and 5 with celecoxib.
RESULTS
Three patients in each group had a complete response to treatment.
CONCLUSIONS
The cyclooxygenase-2 inhibitors may represent an alternative to indomethacin in the treatment of hemicrania continua. Their mechanism of action for this potential indication is unknown.
